A randomized, evaluator-blinded, comparative study to evaluate the efficacy and safety of different injection volumes of botulinum toxin type A, Azzalure, in the glabellar lines

Trial Profile

A randomized, evaluator-blinded, comparative study to evaluate the efficacy and safety of different injection volumes of botulinum toxin type A, Azzalure, in the glabellar lines

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Glabellar lines
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Q-Med
  • Most Recent Events

    • 12 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 04 Jun 2014 According to the ClinicalTrials.gov record, planned end date changed from 17 Jan 2015 to 1 Nov 2014.
    • 04 Jun 2014 New source identified and integrated (ClinicalTrials.gov record: NCT02108158)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top